Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12264949 | 0.89 | DGAT1 (0.37) | CNR2DGAT1 | |
| Trifluoroacetic Acid SCHEMBL2547129 | 0.81 | DGAT1 (0.37) | ALDH1A1DGAT1 | |
| SCHEMBL30066024 | 0.76 | KDM4C (0.42) | ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL2366949 | 0.73 | DGAT1 (0.34) | ALDH1A1DGAT1 | |
| SCHEMBL31067316 | 0.72 | KDM4C (0.39) | ALDH1A1 | |
| SCHEMBL17399505 | 0.72 | DGAT1 (0.39) | CNR2ALDH1A1DGAT1 | |
| Trifluoroacetic Acid SCHEMBL28075338 | 0.71 | KCNN4 (0.38) | ALDH1A1DGAT1 | |
| SCHEMBL28959553 | 0.69 | L3MBTL1 (0.42) | CNR2DGAT1 | |
| Trifluoroacetic Acid SCHEMBL2267588 | 0.68 | ALDH1A1 (0.44) | ALDH1A1 | |
| SCHEMBL4463196 | 0.68 | KDM4C (0.42) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9227995-B2 | Peptides | Jacobsen, Øyvind (NO) | 2016-01-05 | — | — | US | disclosed |
| US-20110263479-A1 | Peptides | UNIVERSITETET I OSLO (NO) | 2011-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263479-A1 | Peptides | VIP, NGLY1, NPPA | CNR2 4875/4885ALDH1A1 4879/4885DGAT1 4788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.